<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; CGEN</title>
	<atom:link href="http://www.stockbloghub.com/tag/cgen/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Tue, 22 May 2012 18:53:06 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(SIGA) These Healthcare Stocks Are Ready to Move Next Week</title>
		<link>http://www.stockbloghub.com/2011/01/07/siga-these-healthcare-stocks-are-ready-to-move-next-week/64553</link>
		<comments>http://www.stockbloghub.com/2011/01/07/siga-these-healthcare-stocks-are-ready-to-move-next-week/64553#comments</comments>
		<pubDate>Fri, 07 Jan 2011 18:11:43 +0000</pubDate>
		<dc:creator>InvestmentU</dc:creator>
				<category><![CDATA[Drug Manufacturers - Other]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Athenahealth Inc]]></category>
		<category><![CDATA[ATHN]]></category>
		<category><![CDATA[CGEN]]></category>
		<category><![CDATA[Compugen Limited]]></category>
		<category><![CDATA[DCTH]]></category>
		<category><![CDATA[Delcath Systems Inc.]]></category>
		<category><![CDATA[Eli Lilly & Company]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[LLY]]></category>
		<category><![CDATA[MCK]]></category>
		<category><![CDATA[McKesson Corporation]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[Merck & Company Inc]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[MOH]]></category>
		<category><![CDATA[Molina Healthcare Inc.]]></category>
		<category><![CDATA[MRK]]></category>
		<category><![CDATA[Nektar Therapeutics]]></category>
		<category><![CDATA[NKTR]]></category>
		<category><![CDATA[PFE]]></category>
		<category><![CDATA[Pfizer Inc.]]></category>
		<category><![CDATA[SIGA]]></category>
		<category><![CDATA[SIGA Technologies Inc]]></category>
		<category><![CDATA[TEVA]]></category>
		<category><![CDATA[Teva Pharmaceutical Industries Limited]]></category>
		<category><![CDATA[WellPoint Inc.]]></category>
		<category><![CDATA[WLP]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=64553</guid>
		<description><![CDATA[by Marc Lichtenfeld, Investment U’s Senior Analyst Wednesday, January 5, 2011: Issue #1421 Once again, I’ve secured my golden ticket to the most important healthcare event of the year. In the past, I’ve described the JP Morgan Healthcare Conference as the Super Bowl of the healthcare investing world. That’s no exaggeration either, as industry executives and investors jet in from all over the world to attend. And with hotels, restaurants and even the 37 Starbucks in Union Square packed with people looking for and providing information, even those without an invitation still hit San Francisco just to be near the action. It’s the place to get the latest news on drug development, research funding, and the companies that could be on the cusp of greatness. And for the past few ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/01/07/siga-these-healthcare-stocks-are-ready-to-move-next-week/64553/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CGEN) Compugen Limited Raises $20 Million in Share Sale</title>
		<link>http://www.stockbloghub.com/2009/12/31/cgen-compugen-limited-raises-20-million-in-share-sale/24008</link>
		<comments>http://www.stockbloghub.com/2009/12/31/cgen-compugen-limited-raises-20-million-in-share-sale/24008#comments</comments>
		<pubDate>Thu, 31 Dec 2009 18:31:05 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CGEN]]></category>
		<category><![CDATA[Compugen Limited]]></category>
		<category><![CDATA[PFE]]></category>
		<category><![CDATA[Pfizer Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=24008</guid>
		<description><![CDATA[Compugen Ltd. (CGEN) announced on Wednesday that it has raised $20 million through a share sale. The Israel-based company sold approximately 4.1 million ordinary shares at an average price of $4.91 each in the open market during the period November 13, 2009 to December 29, 2009. Compugen is engaged in drug and diagnostic product candidate discovery and their commercialization through early-stage licensing and co-development agreements. The company’s business is focused on developing and using predictive computer-based discovery platforms to discover therapeutic drug candidates and diagnostic biomarker candidates. The company plans to spend the proceeds from the stock sale for general corporate purposes. Including the offering, Compugen now has total cash reserves of $23 million and plans to deploy a maximum of $8.5 million during 2010. The company also stated that ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/12/31/cgen-compugen-limited-raises-20-million-in-share-sale/24008/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

